454 related articles for article (PubMed ID: 14581976)
1. New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit?
Toop L; Richards D; Saunders B
N Z Med J; 2003 Aug; 116(1180):U556; discussion U556. PubMed ID: 14581976
[No Abstract] [Full Text] [Related]
2. Direct-to-consumer advertising--where does the public interest lie?
Saunders B
N Z Med J; 2003 Aug; 116(1180):U557; discussion U557. PubMed ID: 14581978
[No Abstract] [Full Text] [Related]
3. Direct-to-consumer advertising is more profitable if it is misleading.
Mansfield PR; Mintzes B
N Z Med J; 2003 Sep; 116(1182):U610. PubMed ID: 14581959
[No Abstract] [Full Text] [Related]
4. Physicians' negative views of direct-to-consumer advertising (DTCA): the international evidence grows.
Toop L; Richards D
N Z Med J; 2004 Jun; 117(1195):U905. PubMed ID: 15282619
[No Abstract] [Full Text] [Related]
5. DTCA not real advertising issue.
Saunders B
N Z Med J; 2003 Sep; 116(1182):U611. PubMed ID: 14581960
[No Abstract] [Full Text] [Related]
6. The leadership role of general practice in public health: advocating a ban of direct-to-consumer advertising of prescription drugs in New Zealand. 'Possums in the headlights?'.
Toop L; Richards D; Dowell T
Br J Gen Pract; 2003 Apr; 53(489):342-5. PubMed ID: 12879848
[No Abstract] [Full Text] [Related]
7. To inform or persuade? Direct-to-consumer advertising of prescription drugs.
Berndt ER
N Engl J Med; 2005 Jan; 352(4):325-8. PubMed ID: 15673797
[No Abstract] [Full Text] [Related]
8. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
Mintzes B; Barer M; Lexchin J; Bassett KL
Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480
[TBL] [Abstract][Full Text] [Related]
9. Striving for quality use of medicines: how effective is Australia's ban on direct-to-consumer prescription medicine advertising?
Brown S
J Law Med; 2009 Feb; 16(4):666-83. PubMed ID: 19297873
[TBL] [Abstract][Full Text] [Related]
10. Is banning direct to consumer advertising of prescription medicine justified paternalism?
Lau Y
J Bioeth Inq; 2005; 2(2):69-74. PubMed ID: 16317865
[TBL] [Abstract][Full Text] [Related]
11. Promotion of prescription drugs to consumers.
Rosenthal MB; Berndt ER; Donohue JM; Frank RG; Epstein AM
N Engl J Med; 2002 Feb; 346(7):498-505. PubMed ID: 11844852
[TBL] [Abstract][Full Text] [Related]
12. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages.
Consum Rep; 2003 Feb; 68(2):33-7. PubMed ID: 12516586
[No Abstract] [Full Text] [Related]
13. Australian consumer responses to DTCA and other pharmaceutical company sponsored advertisements.
Hall DV; Jones SC
Aust N Z J Public Health; 2008 Oct; 32(5):471-8. PubMed ID: 18959553
[TBL] [Abstract][Full Text] [Related]
14. New Zealand general practitioners' views on direct-to-consumer advertising of prescription medicines: a qualitative analysis.
Maubach N; Hoek J
N Z Med J; 2005 May; 118(1215):U1461. PubMed ID: 15915184
[TBL] [Abstract][Full Text] [Related]
15. Direct-to-consumer advertising--education or emotion promotion?
Wolfe SM
N Engl J Med; 2002 Feb; 346(7):524-6. PubMed ID: 11844857
[No Abstract] [Full Text] [Related]
16. Efforts to ban direct-to-consumer advertising in New Zealand: a call to action.
Hoffman JR; Cooper RJ
Br J Gen Pract; 2003 Apr; 53(489):267-9. PubMed ID: 12879824
[No Abstract] [Full Text] [Related]
17. Europe on the brink of direct-to-consumer drug advertising.
Lancet; 2002 May; 359(9319):1709. PubMed ID: 12049853
[No Abstract] [Full Text] [Related]
18. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine.
Allen MC
Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553
[No Abstract] [Full Text] [Related]
19. The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
Morgan S; Mintzes B; Barer M
J Health Serv Res Policy; 2003 Oct; 8(4):237-44. PubMed ID: 14596759
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceuticals and medical devices: business practices. End-of-year issue brief.
Jones TM
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-32. PubMed ID: 18345554
[No Abstract] [Full Text] [Related]
[Next] [New Search]
